Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-7535 multiple-dose safety, tolerability, PK and PD study in adults with obesity
CTR20243724Phase 2Completed
- Sponsor
- Shandong Sende
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-7535, sponsored by Shandong Sende. Started Nov 2024; status: completed.
02
Drugs
HRS-7535
Beyond the preview
Go deeper on CTR20243724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243724.